These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21525162)

  • 1. Decreased circulating soluble Tie2 levels in preeclampsia may result from inhibition of vascular endothelial growth factor (VEGF) signaling.
    Sung JF; Fan X; Dhal S; Dwyer BK; Jafari A; El-Sayed YY; Druzin ML; Nayak NR
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1148-52. PubMed ID: 21525162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling.
    Findley CM; Cudmore MJ; Ahmed A; Kontos CD
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2619-26. PubMed ID: 17901375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease.
    Findley CM; Mitchell RG; Duscha BD; Annex BH; Kontos CD
    J Am Coll Cardiol; 2008 Jul; 52(5):387-93. PubMed ID: 18652948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiopoietin-2/Tie2 signaling involved in TNF-α induced peritoneal angiogenesis.
    Yuan J; Fang W; Lin A; Ni Z; Qian J
    Int J Artif Organs; 2012 Sep; 35(9):655-62. PubMed ID: 23065888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of soluble Tie2 with angiopoietins and pulmonary vascular permeability in septic and nonseptic critically ill patients.
    van der Heijden M; van Nieuw Amerongen GP; van Hinsbergh VW; Groeneveld AB
    Shock; 2010 Mar; 33(3):263-8. PubMed ID: 19543148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.
    Takagi H; Koyama S; Seike H; Oh H; Otani A; Matsumura M; Honda Y
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):393-402. PubMed ID: 12506101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of blood flow-induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling.
    Stone OA; Carter JG; Lin PC; Paleolog E; Machado MJ; Bates DO
    J Physiol; 2017 Mar; 595(5):1575-1591. PubMed ID: 27868196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amniotic fluid angiopoietin-1, angiopoietin-2, and soluble receptor tunica interna endothelial cell kinase-2 levels and regulation in normal pregnancy and intraamniotic inflammation-induced preterm birth.
    Buhimschi CS; Bhandari V; Dulay AT; Thung S; Razeq SS; Rosenberg V; Han CS; Ali UA; Zambrano E; Zhao G; Funai EF; Buhimschi IA
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3428-36. PubMed ID: 20410222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women.
    Rajakumar A; Powers RW; Hubel CA; Shibata E; von Versen-Höynck F; Plymire D; Jeyabalan A
    Placenta; 2009 Jan; 30(1):25-34. PubMed ID: 19010535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
    Ahmad S; Ahmed A
    Circ Res; 2004 Oct; 95(9):884-91. PubMed ID: 15472115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways.
    Liu Z; Guo N; Zhang XJ
    Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system transgenic mouse model recapitulates pathophysiology similar to human preeclampsia with renal injury that may be mediated through VEGF.
    Denney JM; Bird C; Gendron-Fitzpatrick A; Sampene E; Bird IM; Shah DM
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F445-F455. PubMed ID: 27927648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.
    Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E
    Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy.
    Palomo M; Youssef L; Ramos A; Torramade-Moix S; Moreno-Castaño AB; Martinez-Sanchez J; Bonastre L; Pino M; Gomez-Ramirez P; Martin L; Garcia Mateos E; Sanchez P; Fernandez S; Crovetto F; Escolar G; Carreras E; Castro P; Gratacos E; Crispi F; Diaz-Ricart M
    Am J Obstet Gynecol; 2022 Aug; 227(2):277.e1-277.e16. PubMed ID: 35351411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke.
    Zacharek A; Chen J; Cui X; Li A; Li Y; Roberts C; Feng Y; Gao Q; Chopp M
    J Cereb Blood Flow Metab; 2007 Oct; 27(10):1684-91. PubMed ID: 17356562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
    Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.
    Tsatsaris V; Goffin F; Munaut C; Brichant JF; Pignon MR; Noel A; Schaaps JP; Cabrol D; Frankenne F; Foidart JM
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5555-63. PubMed ID: 14602804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Leinonen E; Wathén KA; Alfthan H; Ylikorkala O; Andersson S; Stenman UH; Vuorela P
    J Clin Endocrinol Metab; 2010 Jan; 95(1):126-33. PubMed ID: 19875484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Thrombomodulin in Placental Dysfunction in Preeclampsia.
    Turner RJ; Bloemenkamp KW; Bruijn JA; Baelde HJ
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):728-35. PubMed ID: 26891741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.